Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BAY 1747846 in Healthy Chinese Men
NCT06135181Phase 1Completed
- Sponsor
- Bayer
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of gadoquatrane (2 cohorts), sponsored by Bayer. Primary endpoint: Treatment-Emergent Adverse Events at Day 8. Started Aug 2020; status: completed.
02
Drugs
gadoquatrane
Beyond the preview
Go deeper on NCT06135181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06135181.